Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 226 AL 240

Aducanumab for Alzheimer's disease: The never-ending story that nurses should know

Petch J, Bressington D.

Nurs Open. 2021 Jul;8(4):1524-1526. doi: 10.1002/nop2.878. Epub 2021 Apr 7.

Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease

Nagu P, Parashar A, Behl T, Mehta V.

J Mol Neurosci. 2021 Jul;71(7):1436-1455. doi: 10.1007/s12031-021-01829-3. Epub 2021 Apr 8.

A model-based analysis of the impairment of semantic memory

Westfall HA, Lee MD.

Psychon Bull Rev. 2021 Oct;28(5):1484-1494. doi: 10.3758/s13423-020-01875-9. Epub 2021 Apr 8.

Insulin as a potent bidirectional regulator of GABAergic signalling in the hippocampus of an Alzheimer's disease mouse model

Holm MM.

Acta Physiol (Oxf). 2021 Jun;232(2):e13660. doi: 10.1111/apha.13660. Epub 2021 Apr 18.

Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review

Jin X, Guo JL, Wang L, Zhong X, Yao WF, Gao H, Liu MY.

Eur J Med Chem. 2021 Jun 5;218:113401. doi: 10.1016/j.ejmech.2021.113401. Epub 2021 Mar 27.

Stressed mitochondria: A target to intrude alzheimer's disease

Sharma VK, Singh TG, Mehta V.

Mitochondrion. 2021 Jul;59:48-57. doi: 10.1016/j.mito.2021.04.004. Epub 2021 Apr 8.

Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?

Coppedè F.

Expert Opin Ther Targets. 2021 Apr;25(4):283-298. doi: 10.1080/14728222.2021.1916469. Epub 2021 May 13.

Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease

Müller L, Kirschstein T, Köhling R, Kuhla A, Teipel S.

J Alzheimers Dis. 2021;81(3):855-869. doi: 10.3233/JAD-201540.

Repurposing Licensed Drugs for Use Against Alzheimer's Disease

Norins LC.

J Alzheimers Dis. 2021;81(3):921-932. doi: 10.3233/JAD-210080.

The brain as an insulin-sensitive metabolic organ

Milstein JL, Ferris HA.

Mol Metab. 2021 Oct;52:101234. doi: 10.1016/j.molmet.2021.101234. Epub 2021 Apr 15.

Amyloid-β: A double agent in Alzheimer's disease?

Yu H, Wu J.

Biomed Pharmacother. 2021 Jul;139:111575. doi: 10.1016/j.biopha.2021.111575. Epub 2021 Apr 10.

Structure, Function and Modulation of Striatal-enriched Protein Tyrosine Phosphatase (STEP)

Liang X, Hou X, Fang H.

Curr Med Chem. 2021;28(37):7714-7728. doi: 10.2174/0929867328666210412123304.

Cytokine signaling convergence regulates the microglial state transition in Alzheimer's disease

Lau SF, Fu AKY, Ip NY.

Cell Mol Life Sci. 2021 May;78(10):4703-4712. doi: 10.1007/s00018-021-03810-0. Epub 2021 Apr 13.

Roles and mechanisms of phospholipid transfer protein in the development of Alzheimer's disease

Wang H, Chen MH, Chen W, Zhang JG, Qin SC.

Psychogeriatrics. 2021 Jul;21(4):659-667. doi: 10.1111/psyg.12685. Epub 2021 Apr 13.

Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls

Cisbani G, Rivest S.

Mol Psychiatry. 2021 Oct;26(10):5504-5515. doi: 10.1038/s41380-021-01083-4. Epub 2021 Apr 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias